• Something wrong with this record ?

Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values

I. Černý, J. Prášek, H. Kašpárková,

. 2016 ; 55 (4) : 151-7. [pub] 20160407

Language English Country Germany

Document type Comparative Study, Evaluation Study, Journal Article

OBJECTIVE: The existing most common semi-quantitative systems used for neuroblastoma diagnosis include Curie and SIOPEN scores, which are based on 123I-MIBG planar scans. The purpose of our study was to find out whether a statistically significant difference exists in evaluation based on planar and SPECT/CT scans. We also compared the Curie and SIOPEN methods in terms of their use in regular practice. Patients; method: 45 patients aged 0-10 years; 213 assessments were done in total, and the Curie and SIOPEN scores were determined in each case based on planar and SPECT/CT scans. Student's T-test and the Bland-Altman plot were used for the statistical analysis. RESULTS: Both methods demonstrated a statistically significant difference (p < 0.0001) between planar and SPECT/CT evaluation. In the group of 35 patients with neuroblastoma in clinical stages 3 and 4, in 54% of the patients SPECT/CT detected a lesion that was not visible in the planar scan. In 89% of cases, the lesion was confirmed by another imaging method (CT, MRI). In the group of 10 patients in the clinical stage 1, a difference between planar and SPECT/CT scanning was found only in one patient (10%). In the whole set, 25% patients showed a pathological finding only in soft tissues. CONCLUSION: We recommend to perform semiquantitative evaluation of neuroblastoma based on SPECT/CT scans, particularly in patients in clinical stages 3 and 4. It is advisable to include soft tissues in the score assessment, as well, given that only soft tissues may be involved in up to 25.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013966
003      
CZ-PrNML
005      
20170427102220.0
007      
ta
008      
170413s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.3413/Nukmed-0743-15-05 $2 doi
035    __
$a (PubMed)27054367
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Černý, Igor $u Igor Černý, KNM FN Brno, Jihlavská 20, 62500 Brno, Czech Republic, Tel. +420/777277427, Fax +420/532233840, igicerny@gmail.com.
245    10
$a Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values / $c I. Černý, J. Prášek, H. Kašpárková,
520    9_
$a OBJECTIVE: The existing most common semi-quantitative systems used for neuroblastoma diagnosis include Curie and SIOPEN scores, which are based on 123I-MIBG planar scans. The purpose of our study was to find out whether a statistically significant difference exists in evaluation based on planar and SPECT/CT scans. We also compared the Curie and SIOPEN methods in terms of their use in regular practice. Patients; method: 45 patients aged 0-10 years; 213 assessments were done in total, and the Curie and SIOPEN scores were determined in each case based on planar and SPECT/CT scans. Student's T-test and the Bland-Altman plot were used for the statistical analysis. RESULTS: Both methods demonstrated a statistically significant difference (p < 0.0001) between planar and SPECT/CT evaluation. In the group of 35 patients with neuroblastoma in clinical stages 3 and 4, in 54% of the patients SPECT/CT detected a lesion that was not visible in the planar scan. In 89% of cases, the lesion was confirmed by another imaging method (CT, MRI). In the group of 10 patients in the clinical stage 1, a difference between planar and SPECT/CT scanning was found only in one patient (10%). In the whole set, 25% patients showed a pathological finding only in soft tissues. CONCLUSION: We recommend to perform semiquantitative evaluation of neuroblastoma based on SPECT/CT scans, particularly in patients in clinical stages 3 and 4. It is advisable to include soft tissues in the score assessment, as well, given that only soft tissues may be involved in up to 25.
650    12
$a 3-jodobenzylguanidin $7 D019797
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a vylepšení obrazu $x metody $7 D007089
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a staging nádorů $7 D009367
650    _2
$a neuroblastom $x diagnostické zobrazování $x patologie $7 D009447
650    _2
$a pozitronová emisní tomografie $x metody $7 D049268
650    _2
$a radiofarmaka $7 D019275
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a SPECT/CT $x metody $7 D000072098
655    _2
$a srovnávací studie $7 D003160
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
700    1_
$a Prášek, Jiri
700    1_
$a Kašpárková, Helena
773    0_
$w MED00010324 $t Nuklearmedizin. Nuclear medicine $x 0029-5566 $g Roč. 55, č. 4 (2016), s. 151-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27054367 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170427102540 $b ABA008
999    __
$a ok $b bmc $g 1200431 $s 974744
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 55 $c 4 $d 151-7 $e 20160407 $i 0029-5566 $m Nuklearmedizin $n Nuklearmedizin $x MED00010324
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...